Scopolamine Patch, Extended Release
Product Images NDC 69238-1662

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Scopolamine (NDC 69238-1662). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Scopolamine Transdermal System 1)

Chemical structure of scopolamine depicted as a two-dimensional molecular formula showing atoms and bonds, including a tropane ring combined with an ester-linked phenyl group.*

FDA Label Image

Patch System (Scopolamine Transdermal System 2)

An illustration diagram showing the layered structure of the Scopolamine transdermal patch. The layers, from top to bottom, are labeled as Backing Membrane, Drug Layer, Rate Controlling Membrane, Contact Layer, and Release Liner, depicting the patch's design for extended release.*

FDA Label Image

Figure 1 (Scopolamine Transdermal System 3)

An illustration depicting the Scopolamine 1 mg/3 days transdermal patch. The diagram highlights the patch components: a transparent, dimpled and oversized release liner; a white to off-white adhesive surface; and a tan backing membrane printed with the text 'Scopolamine 1 mg/3 days.'*

FDA Label Image

Figure 2 (Scopolamine Transdermal System 4)

An instructional diagram labeled Figure 2 showing a rectangular package with a dashed line along one edge indicating where to cut the package open. The diagram includes an arrow and text indicating to cut the package open along the dashed line.*

FDA Label Image

Figure 3 (Scopolamine Transdermal System 5)

An instructional diagram showing two hands peeling apart the backing of a transdermal patch, demonstrating the step to open the patch before application. The image illustrates handling the patch carefully by pulling the protective layers apart from the center.*

FDA Label Image

Figure 4 (Scopolamine Transdermal System 6)

An instructional illustration of the Scopolamine transdermal patch showing a hand peeling back the transparent, dimpled, and oversized release liner to expose the white to off-white adhesive surface and the tan printed transdermal system beneath.*

FDA Label Image

Figure 5 (Scopolamine Transdermal System 7)

An illustration showing placement of a tan printed transdermal system on the skin behind the ear of a person's profile, demonstrating the application site for the Scopolamine transdermal patch.*

FDA Label Image

Pouch (Scopolamine Transdermal System 8)

Scopolamine Transdermal System 1 mg/3 days packaging label with front and back panels. Front shows product name, dosage strength, caution about washing hands after application, and Amneal Pharmaceuticals labeler information. Back panel includes detailed dosage and administration instructions, storage conditions, warnings, and distributor contact details.*

FDA Label Image

Carton (Scopolamine Transdermal System 9)

Packaging label for Scopolamine Transdermal System 1 mg/3 days, an extended-release patch for transdermal use. The label displays dosage strength, administration instructions, cautionary notes, and distributor information for Amneal Pharmaceuticals NY LLC. The label also includes a barcode and storage instructions, with a graphic of the patch application area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.